🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Circulating Tumor Cell

cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas NCT07178847NA4 sites📍 Aurillac📍 Clermont-Ferrand📍 Lyon Centre Jean Perrin · Tests: blood sampling A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells. NCT00571389n/a1 site📍 Huntersville BioCytics, Inc. Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer NCT06833632n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial NCT05360290NA1 site📍 Shanghai RenJi Hospital · Tests: GILUPI CellCollector® Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy NCT01961713n/a1 site📍 Boston Massachusetts General Hospital Prospective ctDNA Testing in Large B-Cell Lymphoma NCT07878351n/a2 sites📍 Beijing📍 Beijing Peking University People's Hospital · Tests: Standard-of-care first-line immunochemotherapy containing an anti-CD20 monoclonal antibody and an anthracycline, such a… Potential of Moderate Whole Body Hyperthermia to Enhance Response NCT05821166Phase 21 site📍 Berlin Charite University, Berlin, Germany · Tests: moderate Whole Body Hyperthermia (mWBH) The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer NCT05502523NA4 sites📍 Abington📍 Philadelphia📍 Philadelphia Thomas Jefferson University · Tests: Pulmonary Artery-First Surgical Technique, Biospecimen Collection Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis NCT07030283Phase 11 site📍 Aurora University of Colorado, Denver · Tests: Paclitaxel, NALIRIFOX A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC NCT07058519Phase 21 site📍 Shanghai Shanghai Chest Hospital · Tests: Osimertinib-based adaptive treatment, Osimertinib 80 MG Detection of the BRAF V600E Mutation in Liquid Biopsy Using the CRISPR/Cas12a System NCT07870265NA1 site📍 Brno Masaryk Memorial Cancer Institute · Tests: Novel CRISPR/Cas12a Electrochemical Bioassay, Reference Standard Molecular Diagnostics (NGS and ddPCR), Serial Peripher… EUS Guided HVA and PVA for Circulating Tumor DNA in Patients NCT04782557NA1 site📍 Hong Kong Chinese University of Hong Kong · Tests: EUS-guided portal vein and hepatic vein aspiration PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC NCT06977074Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: PD-1 inhibitor, Platinum Doublet Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401) NCT06561178n/a1 site📍 Guangzhou Sun Yat-Sen University Cancer Center · Tests: molecular residual disease detection Prospective Monocentric Study Evaluating the Circulating NK Cells Phenotype and the ImmunoScore® in Patients With Non Metastatic Rectal Cancer NCT06536127NA1 site📍 Avignon Institut Sainte Catherine · Tests: Blood samples Circulating Immunes Cells, Cytokines and Brain Radiotherapy NCT05082961NA1 site📍 Caen Centre Francois Baclesse · Tests: Collection of blood samples Rarecells Molecular Biomarkers for Early Detection of Lung Cancer NCT06546007n/a1 site📍 Roma Rarecells Diagnostics SAS · Tests: CTC-DNA The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study NCT04957901n/a1 site📍 Guangzhou Sun Yat-sen University · Tests: Pediatric lymphoma protocol Rectal Cancer CTC Trial NCT07194616NA4 sites📍 Olomouc📍 Olomouc📍 Ostrava University Hospital Ostrava · Tests: Primary Surgery, Neoadjuvant radiochemotherapy and surgery Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer NCT05889247NA5 sites📍 Hillerød📍 Næstved📍 Roskilde Zealand University Hospital · Tests: Circulating tumor DNA treatment monitoring ctDNA in Cutaneous Squamous Cell Carcinoma NCT06875609n/a1 site📍 Boston Massachusetts Eye and Ear Infirmary · Tests: Blood and Tissue Collection Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age. NCT04902937n/a1 site📍 Jena University of Jena · Tests: Adjuvant radiotherapy, neoadjuvant and adjuvant chemotherapy Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors NCT05831631n/a1 site📍 Milan Pietro Mortini, MD, Prof. · Tests: Circulating leukocytes immunophenotype, Tumor sampling Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL) NCT06088381Phase 25 sites📍 Baltimore📍 Baltimore📍 Bel Air University of Maryland, Baltimore · Tests: Experimental Observation, Observation per Standard of Care, Adjuvant Treatment per Standard of Care, Circulating Tumor … Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90 NCT07303712n/a1 site📍 Palo Alto Palo Alto Veterans Institute for Research Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA NCT05334277Phase 226 sites📍 Changchun📍 Chengdu📍 Dongguan Sun Yat-sen University · Tests: Furmonertinib, Furmonertinib, Furmonertinib/Pemetrexed/Carboplatin, Furmonertinib/Pemetrexed/Carboplatin/Bevacizumab Neoadjuvant Tebentafusp for Uveal Melanoma NCT06414590Phase 22 sites📍 Philadelphia📍 Philadelphia Thomas Jefferson University · Tests: Tebentafusp-Tebn Relationship Between Circulating Sclerostin and Bone Lesions in Patients With Mastocytosis NCT06440148n/a1 site📍 Lublin Medical University of Lublin · Tests: SCLEROSTIN Targeted Radionuclide Therapy in Metastatic Prostate Cancer Using a New PSMA Ligand Radiolabelled With Terbium-161 (161Tb-SibuDAB) - Dose Identification/Escalation Phase Ia/b Study NCT06343038Phase 11 site📍 Basel University Hospital, Basel, Switzerland · Tests: Injection, 161Tb-SibuDAB,1GBq, Injection, 177Lu-PSMA-I&T, 1GBq, Injection, 161Tb-SibuDAB, Dose Escalation Using ctDNA to Determine Therapies for Lung Cancer NCT04966663Phase 21 site📍 Toronto University Health Network, Toronto · Tests: Nivolumab, Pemetrexed, Gemcitabine, Cisplatin, Carboplatin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy